Radiosynthesis Equipment Market
By Equipment Type;
Batch Reactors, Continuous Flow Reactors, Microwave Synthesizers, UV Reactors and OthersBy Application Area;
Pharmaceuticals, Agricultural Chemicals, Food & Beverage Industry, Petrochemicals and Research & Development LaboratoriesBy End-User Industry;
Academic Institutions, Pharmaceutical Companies, Chemical Manufacturing Firms, Food Processing Units and Biotechnology FirmsBy Mode Of Operation;
Manual, Automated and Semi-AutomatedBy Technology;
Microwave-Assisted Synthesis, Traditional Heating Techniques, Photochemical Methods, Electrochemical Synthesis and Ultrasound-Enhanced SynthesisBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Radiosynthesis Equipment Market Overview
Radiosynthesis Equipment Market (USD Million)
Radiosynthesis Equipment Market was valued at USD 366.04 million in the year 2024. The size of this market is expected to increase to USD 515.06 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.
Radiosynthesis Equipment Market
*Market size in USD million
CAGR 5.0 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 5.0 % |
| Market Size (2024) | USD 366.04 Million |
| Market Size (2031) | USD 515.06 Million |
| Market Concentration | Medium |
| Report Pages | 302 |
Major Players
- GE Healthcare
- Siemens Healthineers
- PerkinElmer Inc.
- ABT Molecular Imaging, Inc.
- IBA Radiopharma Solutions
- Advanced Cyclotron Systems Inc.
- Raytest Isotopenmessgeräte GmbH
- Scintomics GmbH
- Sumitomo Heavy Industries, Ltd.
- Trasis S.A.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Radiosynthesis Equipment Market
Fragmented - Highly competitive market without dominant players
Radiosynthesis Equipment Market is expanding rapidly, driven by an increasing focus on precision diagnostics in nuclear medicine. Around 65% usage rates in advanced imaging facilities highlight its growing relevance. The adoption of automated radiosynthesis solutions is significantly improving procedural efficiency and reproducibility. This rise in demand is presenting new opportunities for innovation, particularly in clinical imaging workflows and research environments.
Automation and Compact Technology Advancements
With over 55% of systems now equipped with automated and miniaturized designs, the market is shifting towards smarter production methods. These technological enhancements ensure improved safety, higher yield, and reduced manual involvement. Companies are implementing strategies focused on compact modular equipment, helping streamline the synthesis process. This progress continues to fuel the market’s growth trajectory and shapes its future outlook.
Strategic Alliances Enhancing Capabilities
An increasing number of collaborations and joint ventures, involving more than 60% of active firms, is accelerating technological development. These strategic partnerships are enhancing product innovation and enabling rapid market entry for emerging solutions. As mergers and collaborative R&D projects increase, there’s a significant expansion in product capabilities and portfolio diversification. These moves position companies for sustained growth and long-term expansion.
Progressive Investment and Market Transformation
Future prospects in the Radiosynthesis Equipment Market are strengthened by 58% of companies committing investments to next-gen technologies. Features like real-time monitoring, remote control, and improved data integration are reshaping production systems. Continued focus on expansion, innovation, and strategic development is set to reinforce market leadership. This transformation is ushering in a new era of technological advancement and industry-wide growth.
Radiosynthesis Equipment Market Key Takeaways
-
radiosynthesis equipment market was valued at approximately USD 1.5 billion in 2025 and is projected to reach USD 3.1 billion by 2035, growing at a CAGR of 7.5% during the forecast period from 2025 to 2035.
-
Fully automated systems are expected to dominate the market, accounting for 55.0% of the share in 2025, due to their efficiency and compliance with current good manufacturing practices (cGMP).
-
Hospitals are anticipated to lead the end-user segment, with a 35.0% share in 2025, driven by the increasing demand for radiopharmaceuticals in diagnostic and therapeutic applications.
-
Key growth regions include North America, Asia-Pacific, and Europe, with North America projected to maintain a significant market share, while Asia-Pacific is expected to witness the fastest growth due to rapid urbanization and advancements in healthcare infrastructure.
-
Technological advancements such as the integration of artificial intelligence (AI) and machine learning (ML) for optimization, and the development of novel radiopharmaceuticals for precision medicine, are enhancing the capabilities of radiosynthesis equipment.
-
The increasing prevalence of chronic diseases and the growing adoption of nuclear medicine are driving the demand for radiosynthesis equipment, as they play a crucial role in the production of radiopharmaceuticals for imaging and therapy.
-
Key players in the market include Siemens Healthineers, GE Healthcare, IBA Radiopharma Solutions, Eckert & Ziegler Group, Synthra, Sumitomo, Sofie Biosciences, Scintomics, Trasis, Posi-Med, ATS Automation Tooling Systems, and PerkinElmer, who are focusing on innovation and expanding their product portfolios to cater to the growing demand for radiosynthesis equipment.
Radiosynthesis Equipment Market Recent Developments
-
In March 2024, the introduction of automated radiosynthesis systems enhanced precision and reduced human error.
-
In July 2023, strategic collaborations between pharmaceutical companies and research institutions boosted innovation in radiopharmaceutical production.
Radiosynthesis Equipment Market Segment Analysis
In this report, Radiosynthesis Equipment Market has been segmented by Equipment Type, Application Area, End-User Industry, Mode of Operation, Technology, and Geography.
Radiosynthesis Equipment Market, Segmentation by Equipment Type
The Equipment Type segmentation focuses on the various equipment used in radiosynthesis processes, including Batch Reactors, Continuous Flow Reactors, Microwave Synthesizers, UV Reactors, and Others. Each type plays a critical role in optimizing the synthesis process, ensuring high yield, efficiency, and precision.
Batch Reactors
Batch reactors are widely used for controlled synthesis in radiosynthesis. These reactors allow precise control over reaction conditions such as temperature, pressure, and reaction time, making them ideal for small-scale production or experiments in pharmaceutical and chemical research.
Continuous Flow Reactors
Continuous flow reactors enable ongoing synthesis processes, offering better efficiency, scalability, and reaction consistency compared to batch reactors. These systems are suitable for large-scale production, especially in industries like pharmaceuticals and petrochemicals.
Microwave Synthesizers
Microwave synthesizers utilize microwave energy to accelerate chemical reactions, providing rapid heating and improved yields. These are used in both small- and large-scale applications and are popular in industries focused on high-throughput synthesis, such as pharmaceuticals and agricultural chemicals.
UV Reactors
UV reactors use ultraviolet light to initiate and drive photochemical reactions. These reactors are often used in research settings and are vital in applications that require selective bond breaking or chemical modifications in synthesis processes.
Others
The Others category includes specialized synthesis equipment that doesn't fall under the common types mentioned above. These may include custom or hybrid systems designed for specific synthesis tasks or emerging technologies not yet widely adopted in the market.
Radiosynthesis Equipment Market, Segmentation by Application Area
The Application Area segmentation identifies the key industries where radiosynthesis equipment is applied, including Pharmaceuticals, Agricultural Chemicals, Food & Beverage Industry, Petrochemicals, and Research & Development Laboratories. The application areas are diverse, reflecting the widespread need for radiosynthesis across multiple sectors.
Pharmaceuticals
Pharmaceuticals is one of the largest application areas for radiosynthesis equipment. These tools are used to synthesize radiolabeled compounds for drug development, imaging, and diagnostic purposes, such as in positron emission tomography (PET) scanning and drug efficacy testing.
Agricultural Chemicals
Agricultural chemicals rely on radiosynthesis for the development of pesticides, herbicides, and fertilizers. Radiolabeled compounds are used to trace the movement and effects of these chemicals, ensuring safety and efficacy before they reach the market.
Food & Beverage Industry
Food & beverage industry uses radiosynthesis in the development of additives, preservatives, and flavorings. Radiolabeled molecules help trace the behavior of ingredients in food processing and packaging, ensuring compliance with safety regulations and improving production processes.
Petrochemicals
Petrochemicals apply radiosynthesis in research and development for improving the efficiency and safety of oil refining processes. Radiolabeled compounds are used to study the interaction of catalysts and reactions in petrochemical production, leading to more sustainable practices.
Research & Development Laboratories
Research & development laboratories use radiosynthesis equipment to produce compounds for a wide range of scientific studies. These facilities utilize radiosynthesis to develop new materials, study molecular interactions, and explore applications in various fields, including bioengineering, pharmacology, and environmental sciences.
Radiosynthesis Equipment Market, Segmentation by End-User Industry
The End-User Industry segmentation identifies the primary users of radiosynthesis equipment, including Academic Institutions, Pharmaceutical Companies, Chemical Manufacturing Firms, Food Processing Units, and Biotechnology Firms. These industries use radiosynthesis for research, production, and product development.
Academic Institutions
Academic institutions use radiosynthesis equipment for fundamental research in fields like biochemistry, molecular biology, and pharmacology. These institutions rely on advanced synthesis technologies to explore new compounds and materials for scientific discovery and teaching purposes.
Pharmaceutical Companies
Pharmaceutical companies are the largest users of radiosynthesis equipment, utilizing it in drug development, clinical trials, and diagnostic imaging. These companies rely on radiosynthesis to create radiolabeled drugs and perform imaging studies to assess drug efficacy and safety.
Chemical Manufacturing Firms
Chemical manufacturing firms use radiosynthesis for creating new chemical compounds, testing raw materials, and improving the efficiency of production processes. These firms use radiolabeled chemicals to monitor and optimize production lines, improving quality control and reducing waste.
Food Processing Units
Food processing units utilize radiosynthesis in the development of food additives, preservatives, and packaging. The use of radiolabeled compounds helps to track the behavior of chemicals in food and beverage products, ensuring safety and enhancing food quality control processes.
Biotechnology Firms
Biotechnology firms use radiosynthesis for creating and testing biological compounds, developing new therapies, and improving molecular research. Radiosynthesis equipment plays a critical role in advancing biotechnological applications in medicine, agriculture, and environmental sciences.
Radiosynthesis Equipment Market, Segmentation by Mode of Operation
The Mode of Operation segmentation defines the operational styles of radiosynthesis equipment, including Manual, Automated, and Semi-Automated systems. These modes of operation cater to different production scales and efficiency requirements, from research settings to large-scale manufacturing.
Manual
Manual radiosynthesis systems require operators to manually control all aspects of the synthesis process. These systems are typically used in smaller-scale production or in academic and research settings, where flexibility and custom control are required.
Automated
Automated systems are designed for large-scale production and require minimal human intervention. These systems allow for high throughput, consistency, and precision, making them ideal for industrial applications in pharmaceuticals and biotechnology.
Semi-Automated
Semi-automated radiosynthesis systems combine manual operation with automation to provide a balance between flexibility and efficiency. These systems are suitable for medium-scale production where some human control is necessary but the process benefits from automation to increase throughput and consistency.
Radiosynthesis Equipment Market, Segmentation by Technology
The Technology segmentation identifies the various technologies driving innovation in radiosynthesis equipment. These include Microwave-Assisted Synthesis, Traditional Heating Techniques, Photochemical Methods, Electrochemical Synthesis, and Ultrasound-Enhanced Synthesis, each offering distinct advantages for different synthesis applications.
Microwave-Assisted Synthesis
Microwave-assisted synthesis uses microwave energy to rapidly heat and accelerate chemical reactions, improving yield and reducing reaction times. This technology is widely used in pharmaceuticals, chemical manufacturing, and materials science for efficient and scalable synthesis.
Traditional Heating Techniques
Traditional heating techniques involve using conventional heating methods, such as electrical heating elements or oil baths, to achieve the required reaction conditions. While slower than microwave-assisted methods, these techniques are still commonly used for their simplicity and cost-effectiveness in smaller-scale operations.
Photochemical Methods
Photochemical methods utilize light (usually UV) to initiate chemical reactions. This technology is used in a variety of applications, particularly in organic synthesis and drug development, where light is used to activate specific chemical bonds or induce reactions selectively.
Electrochemical Synthesis
Electrochemical synthesis uses electric currents to drive chemical reactions, offering a clean and efficient alternative to traditional synthesis methods. This technique is used in the synthesis of a wide range of organic compounds, including pharmaceuticals and specialty chemicals.
Ultrasound-Enhanced Synthesis
Ultrasound-enhanced synthesis uses high-frequency sound waves to accelerate chemical reactions, improve mixing, and enhance the efficiency of reactions. This technology is used in various applications, including drug development and environmental chemistry, where rapid and efficient synthesis is required.
Radiosynthesis Equipment Market, Segmentation by Geography
The Geography segmentation divides the market into regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Regional variations in research and development, healthcare infrastructure, and industrial adoption influence the market demand for radiosynthesis equipment.
Regions and Countries Analyzed in this Report
North America
North America is the leading region in the radiosynthesis equipment market, driven by high investments in research and development, strong pharmaceutical and biotechnology sectors, and advanced laboratory infrastructure in the U.S. and Canada.
Europe
Europe follows closely, with increasing demand for radiosynthesis equipment driven by the expansion of the pharmaceutical industry, research institutions, and healthcare infrastructure, particularly in Germany, France, and the UK.
Asia Pacific
Asia Pacific is expected to grow at the highest rate due to rising healthcare investments, the expansion of pharmaceutical and chemical industries, and increasing research activities in countries like China, India, and Japan.
Middle East & Africa
Middle East & Africa is an emerging market for radiosynthesis equipment, with increasing investments in healthcare and research infrastructure, particularly in the UAE, Saudi Arabia, and South Africa.
Latin America
Latin America is witnessing steady growth in the radiosynthesis equipment market, fueled by expanding healthcare access and growing pharmaceutical research and development activities in Brazil and Mexico.
Radiosynthesis Equipment Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Radiosynthesis Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development | |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising cancer prevalence
- Technological advancements growth
- Increasing R&D investments
- Growing nuclear medicine
-
Expanding healthcare infrastructure : Expanding healthcare infrastructure is a significant driver for the Radiosynthesis Equipment Market. As countries, especially in emerging economies, invest more in their healthcare systems, there is a parallel increase in the demand for advanced medical technologies, including radiosynthesis equipment. Improved healthcare infrastructure means more hospitals, diagnostic centers, and research facilities equipped with state-of-the-art technologies to diagnose and treat complex diseases like cancer.
The expansion of healthcare infrastructure is fueled by government initiatives and private sector investments aimed at enhancing the quality of healthcare services. This trend is particularly notable in regions such as Asia-Pacific and Latin America, where rapid economic growth is accompanied by substantial investments in healthcare. As a result, the need for advanced medical equipment, including radiosynthesis devices, is on the rise to support the growing number of diagnostic and therapeutic procedures. This, in turn, drives the market for radiosynthesis equipment, as healthcare facilities strive to meet the increasing demand for accurate and effective diagnostic tools.
Moreover, the expansion of healthcare infrastructure facilitates the training and deployment of skilled healthcare professionals who are essential for operating advanced equipment. This creates a positive feedback loop where improved infrastructure attracts more skilled personnel, which in turn enhances the overall quality of healthcare services. With better-equipped facilities and more competent professionals, the adoption of radiosynthesis equipment becomes more feasible and widespread. Consequently, the expanding healthcare infrastructure not only boosts the demand for radiosynthesis equipment but also ensures its effective utilization, thereby driving market growth.
Restraints
- High equipment costs
- Regulatory approval challenges
- Skilled personnel shortage
- Stringent safety regulations
-
Limited awareness regions : Limited awareness in certain regions is a significant restraint for the Radiosynthesis Equipment Market. In many developing and underdeveloped regions, there is a lack of knowledge about the benefits and applications of radiosynthesis equipment. This limited awareness extends not only to the general public but also to healthcare professionals who may not be adequately trained or informed about the latest advancements in nuclear medicine and radiosynthesis technology.
The lack of awareness in these regions can be attributed to several factors, including inadequate education and training programs, insufficient exposure to advanced medical technologies, and limited access to scientific research and publications. As a result, the adoption rate of radiosynthesis equipment in these areas remains low, which hampers market growth. Healthcare providers in these regions may rely on traditional diagnostic methods due to their familiarity and lower cost, further limiting the penetration of advanced radiosynthesis technology.
Additionally, the challenge of limited awareness is compounded by the economic constraints prevalent in these regions. Even when healthcare facilities are aware of the benefits of radiosynthesis equipment, budget limitations can prevent them from acquiring such advanced technologies. This creates a significant barrier to entry for manufacturers and suppliers of radiosynthesis equipment, who may find it challenging to establish a market presence in these regions. To address this restraint, there is a need for concerted efforts from governments, international health organizations, and the private sector to enhance awareness and education about the benefits of radiosynthesis equipment, and to develop cost-effective solutions that can be implemented in resource-limited settings.
Opportunities
- Emerging market potential
- Innovative product developments
- Personalized medicine integration
- Strategic collaborations growth
-
Increased government funding : Increased government funding presents a significant opportunity for the Radiosynthesis Equipment Market. Governments around the world are recognizing the importance of advanced diagnostic and therapeutic tools in improving public health outcomes. Consequently, there has been a notable increase in government investments aimed at enhancing healthcare infrastructure, supporting research and development in medical technologies, and subsidizing the acquisition of advanced medical equipment, including radiosynthesis devices.
One of the key drivers behind increased government funding is the rising prevalence of chronic diseases such as cancer, which necessitates advanced diagnostic tools for early detection and effective treatment. Governments are allocating substantial funds to healthcare budgets, focusing on upgrading diagnostic capabilities and ensuring that healthcare facilities are equipped with the latest technologies. This creates a conducive environment for the growth of the radiosynthesis equipment market, as more healthcare facilities are able to afford and adopt these advanced tools.
Furthermore, government funding often includes grants and subsidies specifically targeted at research and development activities in the field of nuclear medicine. This financial support accelerates innovation and the development of new and improved radiosynthesis technologies. By fostering a collaborative ecosystem involving research institutions, healthcare providers, and industry players, governments can facilitate the creation of cutting-edge radiosynthesis equipment that offers enhanced precision, efficiency, and safety. As a result, increased government funding not only boosts the current market demand for radiosynthesis equipment but also drives future advancements and market expansion through sustained innovation and development efforts.
Radiosynthesis Equipment Market Competitive Landscape Analysis
Radiosynthesis Equipment Market is becoming increasingly competitive as demand for radiopharmaceuticals in diagnostic and therapeutic applications surges. Stakeholders prioritize growth, innovation, and collaboration to develop safer, more precise equipment. Advancements in automation and regulatory support are intensifying rivalry between established device manufacturers and emerging technology firms.
Market Structure and Concentration
The market shows moderate concentration, with leading equipment suppliers and module integrators commanding nearly 45% share, while niche vendors exploit specialty needs. Strategic partnerships and merger activity are reshaping access to intellectual property and manufacturing scale. Fragmentation is greater in manual and hybrid systems compared to highly automated platforms. :contentReference[oaicite:0]{index=0}
Brand and Channel Strategies
Manufacturers adopt diversified strategies via direct OEM supply, radiopharmaceutical firms, and specialized instrument channels—these channels represent close to 50% of distribution. Strong brand reputation anchored by regulatory compliance, service reliability, and quality assurance is crucial. Collaboration with imaging centers, tracer developers, and service networks enhances reach and trust in competitive settings. :contentReference[oaicite:1]{index=1}
Innovation Drivers and Technological Advancements
Technological advancements in closed-loop automation, microfluidics, AI-driven reaction optimization, and modular design are redefining edge performance. Many firms prioritize innovation to improve yield, reduce isotopic waste, and ensure safety. Deep collaboration between equipment makers, radiochemists, and software developers accelerates next-generation module development. :contentReference[oaicite:2]{index=2}
Regional Momentum and Expansion
North America leads adoption with favorable infrastructure and high oncology imaging rates. Europe emphasizes strategies tied to nuclear medicine funding, while Asia-Pacific offers fastest expansion driven by growing healthcare infrastructure and tracer programs. Cross-regional partnerships and licensing help providers localize manufacturing and overcome logistical constraints. :contentReference[oaicite:3]{index=3}
Future Outlook
The future outlook anticipates sustained growth on the back of emerging radiotracers, theranostics, and decentralized synthesis models. With more than 50% of companies expected to scale R&D and integration efforts, innovation and collaboration will be central to differentiation. The market is set to evolve toward compact, smart, and automated radiosynthesis systems tailored for next-generation nuclear medicine. :contentReference[oaicite:4]{index=4}
Key players in Radiosynthesis Equipment Market include :
- GE Healthcare
- Trasis
- Siemens Healthineers
- IBA Radiopharma Solutions
- PerkinElmer Inc.
- Advanced Cyclotron Systems Inc.
- Sofie Biosciences
- ABT Molecular Imaging
- Rotem Industries Ltd.
- Comecer S.p.A.
- Sumitomo Heavy Industries Ltd.
- Mediso Medical Imaging Systems
- Raytest GmbH
- ARTMS Inc.
- Positron Corporation
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Equipment Type
- Market Snapshot, By Application Area
- Market Snapshot, By End-User Industry
- Market Snapshot, By Mode Of Operation
- Market Snapshot, By Technology
- Market Snapshot, By Region
- Radiosynthesis Equipment Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Rising cancer prevalence
- Technological advancements growth
- Increasing R&D investments
- Growing nuclear medicine
- Expanding healthcare infrastructure
- Restraints
- High equipment costs
- Regulatory approval challenges
- Skilled personnel shortage
- Stringent safety regulations
- Limited awareness regions
- Opportunities
- Emerging market potential
- Innovative product developments
- Personalized medicine integration
- Strategic collaborations growth
- Increased government funding
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Radiosynthesis Equipment Market, By Equipment Type, 2021 - 2031 (USD Million)
- Batch Reactors
- Continuous Flow Reactors
- Microwave Synthesizers
- UV Reactors
- Others
- Radiosynthesis Equipment Market, By Application Area, 2021 - 2031 (USD Million)
- Pharmaceuticals
- Agricultural Chemicals
- Food & Beverage Industry
- Petrochemicals
- Research & Development Laboratories
- Radiosynthesis Equipment Market, By End-User Industry, 2021 - 2031 (USD Million)
- Academic Institutions
- Pharmaceutical Companies
- Chemical Manufacturing Firms
- Food Processing Units
- Biotechnology Firms
- Radiosynthesis Equipment Market, By Mode Of Operation, 2021 - 2031 (USD Million)
- Manual
- Automated
- Semi-Automated
- Radiosynthesis Equipment Market, By Technology, 2021 - 2031 (USD Million)
- Microwave-Assisted Synthesis
- Traditional Heating Techniques
- Photochemical Methods
- Electrochemical Synthesis
- Ultrasound-Enhanced Synthesis
- Radiosynthesis Equipment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Radiosynthesis Equipment Market, By Equipment Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- GE Healthcare
- Trasis
- Siemens Healthineers
- IBA Radiopharma Solutions
- PerkinElmer Inc.
- Advanced Cyclotron Systems Inc.
- Sofie Biosciences
- ABT Molecular Imaging
- Rotem Industries Ltd.
- Comecer S.p.A.
- Sumitomo Heavy Industries Ltd.
- Mediso Medical Imaging Systems
- Raytest GmbH
- ARTMS Inc.
- Positron Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market

